Literature DB >> 2769855

The intraprostatic spiral: a new device for insertion with the patient under local anesthesia and with ultrasonic guidance with 3 months of followup.

J Nordling1, H H Holm, P Klarskov, K K Nielsen, J T Andersen.   

Abstract

Acute or chronic urinary retention (median retention volume 1,000 ml.) was relieved successfully in 41 of 45 consecutive patients by insertion of an intraprostatic spiral with the patient under local anesthesia and with ultrasonic guidance. Insertion guided by ultrasound was successful in 35 patients (77 per cent). In 6 patients the spiral was inserted via the traditional endoscopic technique. During 3 months of followup the spiral remained in situ in 27 patients and in 6 it was repositioned. These 33 patients had free voiding with a median maximum flow rate of 13.6 ml. per second. Residual urine volume 1 month after insertion of the spiral was low (median 27 ml.). In 8 patients the spiral was removed during the observation period due to urinary incontinence or retention. The intraprostatic spiral is a favorable alternative to an indwelling catheter in patients awaiting an operation and in those with a high operative risk.

Entities:  

Mesh:

Year:  1989        PMID: 2769855     DOI: 10.1016/s0022-5347(17)38878-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Temporary prostatic urethral stenting as a provocative tool to determine surgical eligibility in complex bladder outlet obstructed patients: our initial experience.

Authors:  Mark D Tyson; Kimberly J Hurd; Rafael N Nunez; Christopher E Wolter; Mitchell R Humphreys
Journal:  Curr Urol       Date:  2012-09-27

Review 2.  Urethral stents in benign prostate hyperplasia.

Authors:  Robert F Donnell
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

3.  Temporary prostatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention.

Authors:  K M Anson; D G Barnes; T P Briggs; G M Watson; R A Miller
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.